Acute Biphenotypic Leukemia (ABL) Recruiting Phase 2 Trials for Dexamethasone (DB01234)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02135874Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute LeukemiaTreatment